- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Boceprevir with peginterferon alfa-2b and ribavirin – November 2012
Boceprevir and ribavirin and peginterferon alfa-2b
Last updated
8 November 2023
